← Leaderboards
Hernando Martin Lopez-Bertoni
Hugo W. Moser Res Inst Kennedy Krieger
$2,014,849
Attributed
$2,014,849
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $406K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,014,849 · 1
By mechanism
R01$2,014,849 · 1
Top collaborators
No co-investigators on record.
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- John J Laterra$16,027,154
- Roger Abounader$10,559,826
- Paul A. Watkins$4,502,851
- Elizabeth Anne Kolar$126,708
Others in their field
Other Emerging Leaders on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Kathleen Maletic Neuzil · Emory University$26,258,144
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Jennifer Marie Suga · Kaiser Foundation Research Institute$21,704,579
Research focus
HeterogeneityInnovationAffectGlioblastomaAdvanced DevelopmentGlioma Cell LineCellsArchitectureAutomobile DrivingChromiumBrain NeoplasmsAggressive TherapyDesignCell ModelElf3 GeneEpigenetic ProcessEstersChemotherapyChromatinGene DeliveryGenerationsGenetic TranscriptionGenomicsIn Vivo
Grant awards (5)
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.$406,044
R01 · FY2025 · NS · contact PI
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.$393,854
R01 · FY2024 · NS · contact PI
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.$406,026
R01 · FY2023 · NS · contact PI
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.$406,017
R01 · FY2022 · NS · contact PI
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.$402,908
R01 · FY2021 · NS · contact PI